HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation
A Arosio(University of Milano-Bicocca), Gessica Sala(University of Milano-Bicocca), Cristina Cereda(University of Milan), Carlo Ferrarese(Azienda Ospedaliera San Gerardo), V. Crippa(University of Milan), Angelo Poletti(University of Milan), Francesca Gerardi(Centro Clinico Nemo), Orietta Pansarasa(Foundation Center), Riccardo Cristofani(University of Milan), Lucio Tremolizzo(Azienda Ospedaliera San Gerardo), Riccardo Sirtori(University of Milano-Bicocca), Nilo Riva(HUN-REN Institute of Experimental Medicine), Christian Lunetta(Istituti Clinici Scientifici Maugeri), Chiara Riva(University of Milan), Virginia Rodriguez‐Menendez(University of Milano-Bicocca)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
October 30, 2019
Cited by 31
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Behavioral and Psychological Effects of Coronavirus Disease-19 Quarantine in Patients With Dementia
|Frontiers in Psychiatry|2020|381